Formulary Search
A to Z of Drugs : G
Records returned : 81 (on 29 May 2025 at 00:22:57).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Capsules
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Not for chronic or acute, non-malignant pain. See separate formulary entry for use in neuropathic pain.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
- Tablets
Restrictions / Comments:
Important
First line gabapentinoid.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Preferred
Patients with severe sleep disturbance, RLS-related / co-morbid pain or history of impulse control disorder
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intra-articular injection
Restrictions / Comments:
Important
For use in MRI arthrogram
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
- Injection
Restrictions / Comments:
Important
Restricted antimicrobial to be used under advice of Microbiology, GUM, HIV, Oncology Specialist
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye gel
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Important
Consultant ophthalmologists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Chewable tablets
- Suspension
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sachets (powder)
Restrictions / Comments:
Important
Licensed up to 2 years of age
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Lifting agent injected into sub-mucosa to raise polyp for snaring during lower GI endoscopy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pessaries
Restrictions / Comments:
Important
Restricted to use by Gynaecology and Obstetrics departments only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
0.3% eye / ear drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subconjunctival injection
Restrictions / Comments:
Important
Gentamicin 80mg/2ml ampoules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
- Injection
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials. This drug requires therapeutic monitoring
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
1.5% preservative free eye drops (unlicensed)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Important
Eye drops applied to the ear
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ear drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
ICU use only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
SASH restricted to specialist monogenic clinic for use in specific diabetic subtypes (unlicensed drug - hospital only prescribing)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release
Restrictions / Comments:
Important
Immediate release tablets are preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not a preferred treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Preferred
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Preferred
https://www.toxbase.org/ . Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Glucose 250mg per ml (75g in 300ml)
Not supplied by Pharmacy at SASH - ordered from NHS Procurement
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral gel
Restrictions / Comments:
Important
40% glucose oral gel.
Not for routine prescribing in primary care. Fast-acting sugary drinks / sweets are usually adequate.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Liquid
Restrictions / Comments:
Important
15g / 60ml glucose liquid. For inclusion in Hypo-kits
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suppositories
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ointment
Restrictions / Comments:
Important
Preferred
0.4% ointment is the 1st-line treatment option in adults.
Use of unlicensed strengths / formulations is not supported.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
- Ointment
Restrictions / Comments:
Important
0.4% ointment is the 1st-line treatment option in adults.
0.1%, 0.2% and 2% creams and ointments are non-formulary
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sublingual spray
- Sublingual tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Patches
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Second line - low resistance inhaler. With low-resistance devices, patients must inhale faster to generate the power to separate the drug molecules, which may be difficult in patients with poor lung function.
Combination with LABA recommended in COPD.
Prescribe by BRAND
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use. Expensive treatment option - consider an alternative. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
1mg/5ml oral solution (sugar free) off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Licensed in children 3 years and over. Expensive treatment option - consider an alternative. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
1mg/5ml oral solution (sugar free). Licensed in children aged 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Oral solution 320mcg/ml (Sialanar brand). Expressed as 400mcg/ml. Licensed in children 3 years and over. NOTE - different strengths of liquid are not bioequivalent. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team.
Links :
Indication :
Status :
Formulations :
- Inhaler (Metered Dose)
Restrictions / Comments:
Important
This is the only LAMA/LABA available in an MDI device. Same cost as other LAMA/LABAs
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Second line - low-resistance device so patients must inhale faster to generate the power to separate the drug molecules, which may be difficult in patients with poor lung function.
Prescribe by BRAND
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Ulcerative Colitis in Adults only.
Prescribe by brand.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Implant
Restrictions / Comments:
Important
Primary Care prescribing appropriate on recommendation from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
EXISTING patients only. Do not initiate in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Patches
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
RSFT Immunology only. Initiation and at least 1 month supply from specialist team before any request to transfer prescribing to primary care.
Links :
Indication :
Status :
Formulations :
- Oral lyophilisates
Restrictions / Comments:
Important
Licensed in children over 5 years of age.
Formulary Status :
Links :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :